OBJECT FOR THE REQUEST: Professional consulting and advice on pharmacology in the context of study design and verification of research strategy of the company at every stage of drug development up to early phase clinical trials in therapeutic areas of lung diseases (including idiopathic pulmonary fibrosis-IPF) and oncology.
After collecting all the information regarding the request for proposal and after analyzing the completeness of the offers, the Commission concludes that the most advantageous offer meeting all the requirements contained in the request has presented:
Douglas W.P. Hay
278 Colket Lane, Strafford,
PA 19087, USA
Total net price of the order execution: 28 800 USD ( 106 971,84zł) 108 092,16 zł
The Commission recommends the Management Board to perform the order in accordance with the offer submitted by Douglas W.P. Hay.